本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

T2 Biosystems

0.0222
0.0000
成交量:391.00
成交额:8.29
市值:62.26万
市盈率:-0.01
高:0.0222
开:0.0222
低:0.0222
收:0.0222
52周最高:1.86
52周最低:0.0002
股本:2,804.54万
流通股本:1,494.91万
量比:0.03
换手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):-4.0799
每股收益(LYR):-19.1867
净资产收益率:-622.14%
总资产收益率:-84.85%
市净率:-0.05
市盈率(LYR):0.00

数据加载中...

2024/09/16

重要事件披露

Form 8-K - Current report
2024/09/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

重要事件披露

Form 8-K - Current report
2024/08/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/29

重要事件披露

Form 8-K - Current report
2024/07/27

SEC问询函

Form CORRESP - Correspondence
2024/07/19

重要事件披露

Form 8-K - Current report
2024/06/01

SEC问询函

Form CORRESP - Correspondence
2024/05/22

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/08

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/05/07

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/05/07

重要事件披露

Form 8-K - Current report
2024/05/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/05/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]